Regenxbio (RGNX) - Sotuvning sof marjinal rentabelligi

REGENXBIO (RGNX) tovar belgisi

REGENXBIO Inc. (RGNX) o'zining noyob DNK platformasini kengaytirmoqda va sanoat gigantlari bilan ittifoqlar orqali innovatsion dori vositalarini bozorga olib chiqmoqda. Kompaniya AAV9 vektorlariga bo'lgan eksklyuziv huquqlardan foydalanib, barqaror royalti to'lovlarini shakllantirmoqda. Sotuvlardan olingan sof foyda marjasi moliyaviy barqarorlikni namoyish etadi, bunda -113.80 qiymati ushbu ko'rsatkichning muvozanatini aks ettiradi. Bu yerdagi narxlar dinamikasi iqtisodiy sikllarga emas, balki klinik sinovlar natijalariga bog'liq.

RGNX: REGENXBIO Inc. Kompaniya sotuv marjasi 04.07.2022 - 20.11.2026

REGENXBIO Corp (RGNX) kompaniyasi koʻrsatkichlari kesimi va tahlili

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:Regenxbio, RGNX
Regenxbio yetakchi tovari

Sof foyda marjasi barcha xarajatlardan keyin qolgan foyda qismini o'lchaydi, bu esa investorga tushumni kapitalga aylantirish samaradorligini baholash imkonini beradi. Umumiy foyda marjalarini tahlil qilish haddan tashqari yuqori xarajatlar xavfini aniqlashga yordam beradi, bu esa REGENXBIO Inc. (RGNX) uchun bio-chiqindilarni qayta ishlash bo'yicha qimmat ESG standartlarini joriy qilishda va gen terapiyasi dori vositalarining energiya talab qiluvchi logistikasini optimallashtirishda juda muhimdir.

Muhim raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX